Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints.

Komatsu N, Takayanagi H.

Front Immunol. 2012 Apr 13;3:77. doi: 10.3389/fimmu.2012.00077. eCollection 2012.

2.

Autoimmune arthritis: the interface between the immune system and joints.

Komatsu N, Takayanagi H.

Adv Immunol. 2012;115:45-71. doi: 10.1016/B978-0-12-394299-9.00002-3. Review.

PMID:
22608255
3.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

4.

Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.

Kaur S, White S, Bartold M.

JBI Libr Syst Rev. 2012;10(42 Suppl):1-12.

PMID:
27820156
5.

T Cell Migration in Rheumatoid Arthritis.

Mellado M, Martínez-Muñoz L, Cascio G, Lucas P, Pablos JL, Rodríguez-Frade JM.

Front Immunol. 2015 Jul 27;6:384. doi: 10.3389/fimmu.2015.00384. eCollection 2015. Review.

6.

[Bone and cartilage destruction in rheumatoid arthritis].

Komatsu N, Takayanagi H.

Clin Calcium. 2012 Feb;22(2):179-85. doi: CliCa1202179185. Review. Japanese.

PMID:
22298070
7.

[Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].

Seemayer CA, Distler O, Kuchen S, Müller-Ladner U, Michel BA, Neidhart M, Gay RE, Gay S.

Z Rheumatol. 2001 Oct;60(5):309-18. Review. German.

PMID:
11759230
8.

Oleanolic acid acetate inhibits rheumatoid arthritis by modulating T cell immune responses and matrix-degrading enzymes.

Choi JK, Kim SW, Kim DS, Lee JY, Lee S, Oh HM, Ha YS, Yoo J, Park PH, Shin TY, Kwon TK, Rho MC, Kim SH.

Toxicol Appl Pharmacol. 2016 Jan 1;290:1-9. doi: 10.1016/j.taap.2015.11.005. Epub 2015 Nov 10.

PMID:
26570984
9.

[Mechanism of bone destruction and the contribution of T lymphocytes].

Komatsu N.

Nihon Rinsho. 2016 Jun;74(6):907-12. Review. Japanese.

PMID:
27311177
10.

IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration.

Tanida S, Yoshitomi H, Ishikawa M, Kasahara T, Murata K, Shibuya H, Ito H, Nakamura T.

Cytokine. 2011 Aug;55(2):237-44. doi: 10.1016/j.cyto.2011.04.020. Epub 2011 May 17.

11.
12.

[Mechanism of bone and cartilage damage in rheumatoid arthritis].

Komatsu N, Takayanagi H.

Clin Calcium. 2015 Dec;25(12):1749-55. doi: CliCa151217491755. Review. Japanese.

PMID:
26608848
13.

Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.

Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK 3rd, Santos LL, Morand EF, David JR, Koch AE.

Arthritis Res Ther. 2006;8(4):R132.

14.

Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling.

Miao CG, Yang YY, He X, Li XF, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J.

Cell Signal. 2013 Oct;25(10):2069-78. doi: 10.1016/j.cellsig.2013.04.002. Epub 2013 Apr 17. Review.

PMID:
23602936
15.

Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.

Azizi G, Jadidi-Niaragh F, Mirshafiey A.

Int J Rheum Dis. 2013 Jun;16(3):243-53. doi: 10.1111/1756-185X.12132. Review.

PMID:
23981743
16.

Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.

Xue M, McKelvey K, Shen K, Minhas N, March L, Park SY, Jackson CJ.

Rheumatology (Oxford). 2014 Dec;53(12):2270-9. doi: 10.1093/rheumatology/keu254. Epub 2014 Jun 29.

PMID:
24982240
17.

Th17 in Animal Models of Rheumatoid Arthritis.

Hashimoto M.

J Clin Med. 2017 Jul 21;6(7). pii: E73. doi: 10.3390/jcm6070073. Review.

18.

Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.

Benedetti G, Miossec P.

Eur J Immunol. 2014 Feb;44(2):339-47. doi: 10.1002/eji.201344184. Review.

19.

Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.

Yamamoto A, Fukuda A, Seto H, Miyazaki T, Kadono Y, Sawada Y, Nakamura I, Katagiri H, Asano T, Tanaka Y, Oda H, Nakamura K, Tanaka S.

Arthritis Rheum. 2003 Sep;48(9):2682-92.

20.

The SCID mouse model: novel therapeutic targets - lessons from gene transfer.

Pierer M, Müller-Ladner U, Pap T, Neidhart M, Gay RE, Gay S.

Springer Semin Immunopathol. 2003 Aug;25(1):65-78. Review.

PMID:
12904892

Supplemental Content

Support Center